IP Verse

Biontech Cell&gene Therapies patent opposition analysis

Get complete Patent Opposition Report for Biontech Cell&gene Therapies

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest patents of Biontech Cell&gene Therapies opposed by its competitors

Explore Biontech Cell&gene Therapies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3294325Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination1
EP3126381Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
EP3294333Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes1

Top competitors of Biontech Cell&gene Therapies